Evercore ISI Increases Mettler-Toledo International (NYSE:MTD) Price Target to $1,450.00

Mettler-Toledo International (NYSE:MTD) had its price target raised by Evercore ISI from $1,375.00 to $1,450.00 in a report issued on Tuesday, Benzinga reports. The firm currently has an in-line rating on the medical instruments supplier’s stock.

Several other brokerages also recently commented on MTD. Stifel Nicolaus upped their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the company a buy rating in a report on Monday, August 5th. Jefferies Financial Group reissued an underperform rating and issued a $1,250.00 price objective (up from $1,230.00) on shares of Mettler-Toledo International in a research report on Monday, June 3rd. The Goldman Sachs Group boosted their price objective on shares of Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the company a neutral rating in a research report on Tuesday, July 9th. Wells Fargo & Company started coverage on shares of Mettler-Toledo International in a research report on Tuesday, August 27th. They issued an equal weight rating and a $1,400.00 price objective for the company. Finally, StockNews.com raised shares of Mettler-Toledo International from a hold rating to a buy rating in a research report on Thursday, July 11th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of Hold and an average price target of $1,363.75.

Mettler-Toledo International Trading Down 0.7 %

Shares of NYSE:MTD opened at $1,452.82 on Tuesday. The company has a market capitalization of $31.03 billion, a price-to-earnings ratio of 40.74, a PEG ratio of 3.75 and a beta of 1.14. Mettler-Toledo International has a 12 month low of $928.49 and a 12 month high of $1,546.93. The firm’s 50-day moving average is $1,425.28 and its 200 day moving average is $1,385.84.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 EPS for the quarter, beating the consensus estimate of $9.00 by $0.65. The company had revenue of $946.75 million for the quarter, compared to the consensus estimate of $929.13 million. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The firm’s revenue was down 3.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $10.19 EPS. As a group, equities analysts forecast that Mettler-Toledo International will post 40.35 EPS for the current fiscal year.

Insider Transactions at Mettler-Toledo International

In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. In related news, insider Christian Magloth sold 1,000 shares of the stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the sale, the insider now owns 734 shares of the company’s stock, valued at $1,044,459.98. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at $6,884,514. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Investors Weigh In On Mettler-Toledo International

Hedge funds and other institutional investors have recently bought and sold shares of the company. Eisler Capital UK Ltd. acquired a new position in Mettler-Toledo International during the 4th quarter valued at approximately $770,000. Daiwa Securities Group Inc. increased its stake in Mettler-Toledo International by 36.6% during the 1st quarter. Daiwa Securities Group Inc. now owns 2,682 shares of the medical instruments supplier’s stock valued at $3,570,000 after purchasing an additional 719 shares in the last quarter. Capital International Investors increased its stake in Mettler-Toledo International by 3.0% during the 4th quarter. Capital International Investors now owns 933,989 shares of the medical instruments supplier’s stock valued at $1,132,891,000 after purchasing an additional 27,386 shares in the last quarter. Norden Group LLC increased its stake in Mettler-Toledo International by 2,701.7% during the 1st quarter. Norden Group LLC now owns 6,640 shares of the medical instruments supplier’s stock valued at $8,840,000 after purchasing an additional 6,403 shares in the last quarter. Finally, Parkman Healthcare Partners LLC acquired a new position in Mettler-Toledo International during the 4th quarter valued at approximately $9,097,000. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.